Pharmaceutical companies, usually not major legislative players, have dramatically increased their presence in Carson City this year, with many new lobbyists registering since a major bill targeted by the industry was introduced in mid-March.

Lobbyists, some of whom have multiple clients, have submitted 67 registrations on behalf of pharmaceutical companies during the 2017 session, more than double the number of pharmaceutical lobbyist registrations over the course of the 2015 legislative session, an analysis of lobbyist reports by The Nevada Independent shows. In all, at least 42 lobbyists have registered to represent 26 companies this legislative session.

At least 11 of those registrations were submitted after Democratic Sen. Yvanna Cancela introduced a major pharmaceutical bill, SB265, on March 14, according to an analysis of lobbyist registrations provided by the Legislative Counsel Bureau to The Nevada Independent. The legislation, which drew ire from the industry during a hearing late last month, would put price controls on certain diabetes drugs, require pharmaceutical sales representatives to be licensed and annually report their activities and mandate disclosure of any pharmaceutical-related contributions by nonprofits in the health care sector.

Many of the 47 lobbyists represent multiple clients. Carrara Nevada president Rocky Finseth and vice president Jenny Reese represent seven pharmaceutical clients: AbbVie, Bayer, GlaxoSmithKline, Greenwich Biosciences, Mallinckrodt Pharmaceuticals, Takeda Pharmaceuticals and PhrMA, the trade association representing pharmaceutical companies in the United States. PhRMA itself has a total of eight lobbyists representing them this session — including its director of state advocacy Saiza Elayda and its vice president of state advocacy Kipp Snider — compared to the three last session.

Four lobbyists with the McMullen Strategic Group — Sam McMullen, Connor Cain, George Ross and Sara Cholhagian — represent three clients, Amgen, Astellas Pharma and the Biotechnology Innovation Organization. Strategies 360’s John Oceguera and Marcus Conklin, two former legislators, represent Eli Lilly and Company along with PhRMA.

The top three insulin manufacturers, who are being sued for allegedly unfairly raising prices and monopolizing the insulin market, all have representation at the Legislature. Eli Lilly has five registered lobbyists, while Novo Nordisk and Sanofi each have one. Eli Lilly only had one lobbyist during the 2015 session, Novo Nordisk had none and Sanofi only had one representative lobbying on behalf of its vaccination arm, Sanofi Pasteur.

Three companies — Boehringer Ingelheim Pharmaceuticals, Johnson & Johnson and Sanofi — didn’t have any representation before mid-March, with AbbVie, Takeda, Eli Lilly and Novartis Services adding additional lobbyists over the last couple of weeks.

Here’s a list of all the pharmaceutical companies and their lobbyists who have registered for the 2017 session. Email megan@thenvindy.com if you spot any companies or lobbyists we missed.

AbbVie:

  • Floreine Kahn
  • Jenny Reese
  • Rocky Finseth

Alkermes:

  • April Grant

Allergan:

  • Jennifer Stoll

Amgen:

  • Brad Jordan
  • Connor Cain
  • Jennifer Fitzgerald
  • Rylan Hanks
  • Samuel McMullen
  • Sara Cholhagian
  • George Ross

Astellas Pharma:

  • Barbara Morrow
  • Connor Cain
  • George Ross
  • Samuel McMullen
  • Sara Cholhagian

Bayer:

  • Craig Swaim
  • Jenny Reese
  • Rocky Finseth

Biogen:

  • Katie Tinney

Biotechnology Innovation Organization (BIO):

  • Brian Warren
  • Connor Cain
  • George Ross
  • Samuel McMullen
  • Sara Cholhagian

Boehringer Ingelheim Pharmaceuticals:

  • Bryan Gresh
  • Cheyanne Cook
  • Sarah Collins

Bristol-Myers Squibb Company:

  • Sarah Ehrlich Swan

Celgene:

  • Sedrick Spencer

Eli Lilly and Company:

  • Bianca Marquez
  • Daniel Howle
  • John Oceguera
  • Marcus Conklin
  • Marla Williams

Genentech:

  • Barbara Lussenhop

Generic Pharmaceutical Association:

  • Jay Parmer

GlaxoSmithKline:

  • Jenny Reese
  • Rocky Finseth

Greenwich Biosciences:

  • Jenny Reese
  • Kurt Stembridge
  • Rocky Finseth

Johnson & Johnson:

  • Jeff Buel
  • Patrick McNaught

Mallinckrodt Pharmaceuticals:

  • Derek Naten
  • Jenny Reese
  • Rocky Finseth

Mylan:

  • Jay Parmer

Novartis Services:

  • David Goldwater
  • Kirby Consier
  • Nikki Bailey-Lundahl

Novo Nordisk:

  • Tom Boyer

PhRMA:

  • Bianca Marquez
  • Jenny Reese
  • John Oceguera
  • Kipp Snider
  • Marcus Conklin
  • Marla Williams
  • Rocky Finseth
  • Saiza Elayda

Purdue Pharma:

  • Robert McElderry

Sanofi:

  • Deanne Calvert

Sunovion Pharmaceuticals:

  • Coleen Lawrence
  • Philip Walsh

Takeda Pharmaceuticals:

  • Jenny Reese
  • Rocky Finseth

Photo courtesy of biologycorner under Creative Commons.

From the Editor

The Nevada Independent is a 501c3 nonprofit. We have generous corporate donors, but we can’t survive on those alone. We need support from our readers. I know you have many commitments. But if you would support our work (or bump up your current donation), we would be forever grateful.
Best,
Jon Ralston
Donate Now
get our morning newsletter,
the daily indy
Correct Us
Ideas & Story Tips
Stars & Struggles
Take a peek into today's education world through the lens of Sunrise Acres Elementary School in Las Vegas.

INDYMATTERS

    CAFECITO CON LUZ

      EN ESPAÑOL

        INDY BLOG

          @TheNVIndy ON TWITTER